Cargando…
Humoral and cellular correlates of a novel immune-related adverse event and its treatment
Immune-related adverse events (irAE) may affect almost any organ system and occur at any point during treatment with immune checkpoint inhibitors (ICI). We present a patient with advanced lung cancer receiving antiprogrammed death 1 checkpoint inhibitor who developed a delayed-onset visual irAE trea...
Autores principales: | Gonugunta, Amrit S, von Itzstein, Mitchell S, Mu-Mosley, Hong, Fattah, Farjana, Farrar, J David, Mobely, Angela, Rashdan, Sawsan, Lai, Sunny, Bhai, Salman F, Bermas, Bonnie L, Karp, David, Li, Quan-Zhen, Wakeland, Edward K, Gerber, David E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655605/ https://www.ncbi.nlm.nih.gov/pubmed/34880115 http://dx.doi.org/10.1136/jitc-2021-003585 |
Ejemplares similares
-
Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors
por: Mundra, Vatsala, et al.
Publicado: (2023) -
Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report
por: Gonugunta, Amrit S., et al.
Publicado: (2022) -
Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
por: von Itzstein, Mitchell S., et al.
Publicado: (2022) -
Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
por: von Itzstein, Mitchell S., et al.
Publicado: (2022) -
Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon
por: Khan, Shaheen, et al.
Publicado: (2020)